Document is current
Any future updates will be listed below
-
Authors
Baxi, Emily G.
Shanahan, Megan
Pham, Daniel L.
Beck, Veronica C.
Barcomb, Kelsey M.
Nestler, Eric J.
Frye, Mark A.
Altimus, Cara M.
Burdick, Katherine E.
-
Funding
Funding for this research was provided by:
BD2 Breakthrough Discoveries for thriving with Bipolar Disorder
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 19 October 2025
First Online: 22 December 2025
Declarations
:
: The BD 2 Integrated Network Longitudinal Cohort Study for Deep Phenotyping in Bipolar Disorder was centrally approved (initial approval March 28, 2024, last amendment June 30, 2025) by BRANY IRB (# BD2IN-LCP-100/BRANY File # 23-08-719-Master File (CIRB)). All participating clinic sites subsequently ceded.
: Not applicable.
: KEB receives honorarium from Breakthrough Discoveries for thriving with Bipolar Disorder (BD2) for her role as Chair of the Scientific Steering Committee. She also receives honorarium as a member of the scientific advisory board for Alto Neuroscience, and Suven Life Sciences. MAF receives grant support from Assurex Health, Baszucki Group, Breakthrough Discoveries for Thriving with Bipolar Disorder (BD2) and Mayo Foundation. He receives honoraria from Carnot Laboratories and American Physician Institute and royalties from Chymia LLC.
